Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Contract/Agreement, Product/Service, Nonprofit

PointClickCare Revolutionizes Parkinson's Disease Psychosis Diagnosis with Innovative Screening Tool


PointClickCare, the leading cloud-based software platform for the senior care market, in partnership with ASCP, a membership association that represents pharmacists, health care professionals, and students serving the unique medication needs of older adults, announced a new tool to help screen patients who may be experiencing Parkinson's Disease Psychosis.

It is common for those who have Parkinson's Disease (PD) to experience Parkinson's Psychosis, an ailment that can manifest in different behaviors such as hallucinations and delusions. Parkinson's Psychosis is often misdiagnosed, and patients are subsequently put on antipsychotic medication rather than treating underlying issues. Further, behaviors associated with Parkinson's Psychosis may only be exhibited at night, exacerbating the likelihood that providers remain unaware of the symptoms.

Given challenging diagnosis factors and how prevalent PD is, PointClickCare saw an urgent need to help senior care providers easily diagnose accompanying psychosis. According to the Parkinson's Foundation, more than 10 million people worldwide live with PD. In addition to enabling earlier diagnosis, the screener tool will facilitate a more standardized care process for this disease, allowing the industry to collect better data that can ultimately lead to better outcomes.

The tool is programmed to ask patients a handful of research-based questions covering topics such as hallucinations and delusions. Once the screening is complete, staff can have a conversation with the provider centered on responses. While the tool is not prescriptive, it collects information that enables conversations and provides care planning suggestions for the team.

"Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson's Psychosis," said Bill Stuart, Clinical Product Strategist, PointClickCare. "At PointClickCare, we understand the industry needs a standard approach to care by delivering standardized content that ultimately leads to standard data. Standard data is the only way to look across facilities to identify trends that can potentially provide new workflows and/or lead to new treatments."

Resulting data collected in the screener will be leveraged as part of PointClickCare's Lighthouse initiative, to further Parkinson's Psychosis treatment research. This announcement also comes on the heels of the release of PointClickCare's Infection Prevention and Control (IPC) solution, a clinical workflow and intelligence solution that helps Infection Preventionists and care teams perform ongoing resident surveillance focused on infection prevention.

"Parkinson's Psychosis impacts many older people worldwide, and we're thrilled to play a role in enabling earlier detection so that patients can receive the treatment they need sooner," said ASCP's chief executive, Chad Worz, PharmD, BCGP. "We are excited to have another tool for care teams to facilitate a more standardized care process for Parkinson's Disease and we are excited for the role that pharmacists play in this process."

The Parkinson's Psychosis screener is currently available to all customers who wish to opt-in as part of PointClickCare's free clinical content offering. For more information, visit PointClickCare's Skilled Nursing page.

About PointClickCare

PointClickCare Technologies Inc., helps long-term and post-acute care (LTPAC) providers gain the confidence they need to navigate the new realities of value-based healthcare ? achieving preferred status in competitive and shrinking networks, optimizing financial and operational health, attracting and retaining the right staff, and connecting to the right partners and insights needed to effectively manage and mitigate risk. Recognized by Forbes as one of the Top 100 Private Cloud Companies and acknowledged by KLAS Research as Best in KLAS Vendor for Long-term Care, PointClickCare leads the way in creating cloud-based environments where providers, patients, and payers eliminate data silos between care settings, connecting stakeholders to meaningful insights. With a suite of fully-integrated applications powered by an interoperable, mobile friendly, and regulatory- compliant electronic health record and revenue cycle management platform, PointClickCare helps care providers connect and collaborate within their care network. Over 21,000 skilled nursing facilities, senior living communities, and home health agencies use PointClickCare today, making it the North American healthcare IT market leader for the LTPAC industry. For more information on PointClickCare's software solutions, please visit www.pointclickcare.com.

About ASCP: Empowering Pharmacists. Transforming Aging.

ASCP is a membership association that represents pharmacists, health care professionals, and students serving the unique medication needs of older adults. ASCP is an international organization with members located in all 50 states, Puerto Rico, and 12 countries. The society's mission is to promote healthy aging by empowering pharmacists with education, resources, and innovative opportunities. Learn more at ASCP.com.

Founded in 1969, ASCP is a 501(c)(6) non-profit organization based in Alexandria, Virginia. The ASCP Foundation is a 501(c)(3) non-profit organization; its purpose is to carry out the charitable ? including scientific, literary, and educational ? purposes of ASCP.


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: